Abstract
Autism spectrum conditions have been hypothesized to be an exaggeration of normal male low-empathizing and high-systemizing behaviors. We tested this hypothesis at the molecular level by performing comprehensive multi-analyte profiling of blood serum from adult subjects with Asperger's syndrome (AS) compared with controls. This led to identification of distinct sex-specific biomarker fingerprints for male and female subjects. Males with AS showed altered levels of 24 biomarkers including increased levels of cytokines and other inflammatory molecules. Multivariate statistical classification of males using this panel of 24 biomarkers revealed a marked separation between AS and controls with a sensitivity of 0.86 and specificity of 0.88. Testing this same panel in females did not result in a separation between the AS and control groups. In contrast, AS females showed altered levels of 17 biomarkers including growth factors and hormones such as androgens, growth hormone and insulin-related molecules. Classification of females using this biomarker panel resulted in a separation between AS and controls with sensitivities and specificities of 0.96 and 0.83, respectively, and testing this same panel in the male group did not result in a separation between the AS and control groups. The finding of elevated testosterone in AS females confirmed predictions from the ‘extreme male brain’ and androgen theories of autism spectrum conditions. We conclude that to understand the etiology and development of autism spectrum conditions, stratification by sex is essential.
This is a preview of subscription content, access via your institution
Access options
Subscribe to this journal
Receive 12 print issues and online access
$259.00 per year
only $21.58 per issue
Buy this article
- Purchase on SpringerLink
- Instant access to full article PDF
Prices may be subject to local taxes which are calculated during checkout
Similar content being viewed by others
References
American Psychiatric Association. Diagnostic and Statistical Manual of Mental disorders. 4th Edition Text Revision: DSM-IV-TR (2000). ISBN: 0890420256.
Volkmar FR, State M, Klin A . Autism and autism spectrum disorders: diagnostic issues for the coming decade. J Child Psychol Psychiatry 2009; 50: 108–115.
Baron-Cohen S, Scott FJ, Allison C, Williams J, Bolton P, Matthews FE et al. Prevalence of autism-spectrum conditions: UK school-based population study. Br J Psychiatry 2009; 194: 500–509.
Wing L . Asperger's syndrome: a clinical account. Psychol Med 1981; 11: 115–129.
Baron-Cohen S . The extreme male brain theory of autism. Trends Cogn Sci 2002; 6: 248–254.
Knickmeyer RC, Wheelwright S, Baron-Cohen SB . Sex-typical play: masculinization/defeminization in girls with an autism spectrum condition. J Autism Dev Disord 2008; 38: 1028–1035.
Baron-Cohen S, Knickmeyer RC, Belmonte MK . Sex differences in the brain: implications for explaining autism. Science 2005; 310: 819–823.
Auyeung B, Baron-Cohen S, Ashwin E, Knickmeyer R, Taylor K, Hackett G . Fetal testosterone and autistic traits. Br J Psychol 2009; 100 (Pt 1): 1–22.
Auyeung B, Baron-Cohen S, Chapman E, Knickmeyer R, Taylor K, Hackett G . Foetal testosterone and the child systemizing quotient. Eur J Endocrinol 2006; 155 (suppl_1): S123.
Chapman E, Baron-Cohen S, Auyeung B, Knickmeyer R, Taylor K, Hackett G . Fetal testosterone and empathy: evidence from the empathy quotient (EQ) and the ‘reading the mind in the eyes’ test. Soc Neurosci 2006; 1: 135–148.
Ingudomnukul E, Baron-Cohen S, Wheelwright S, Knickmeyer R . Elevated rates of testosterone-related disorders in women with autism spectrum conditions. Horm Behav 2007; 51: 597–604.
Manning JT, Baron-Cohen S, Wheelwright S, Sanders G . The 2nd to 4th digit ratio and autism. Dev Med Child Neurol 2001; 43: 160–164.
Henningsson S, Jonsson L, Ljunggren E, Westberg L, Gillberg C, Rastam M et al. Possible association between the androgen receptor gene and autism spectrum disorder. Psychoneuroendocrinology 2009; 34: 752–761.
Sugie Y, Sugie H, Fukuda T, Osawa J . Study of HOXD genes in autism particularly regarding the ratio of second to fourth digit length. Brain Dev 2009; 32: 356–361.
Chakrabarti B, Dudbridge F, Kent L, Wheelwright S, Hill-Cawthorne G, Allison C et al. Genes related to sex steroids, neural growth, and social-emotional behavior are associated with autistic traits, empathy, and Asperger syndrome. Autism Res 2009; 2: 157–177.
Courchesne E, Carper R, Akshoomoff N . Evidence of brain overgrowth in the first year of life in autism. JAMA 2003; 290: 337–344.
Castellani ML, Conti CM, Kempuraj DJ, Salini V, Vecchiet J, Tete S et al. Autism and immunity: revisited study. Int J Immunopathol Pharmacol 2009; 22: 15–19.
Vojdani A, Mumper E, Granpeesheh D, Mielke L, Traver D, Bock K et al. Low natural killer cell cytotoxic activity in autism: the role of glutathione, IL-2 and IL-15. J Neuroimmunol 2008; 205: 148–154.
Enstrom AM, Van de Water JA, Ashwood P . Autoimmunity in autism. Curr Opin Investig Drugs 2009; 10: 463–473.
Bossuyt PM, Reitsma JB, Bruns DE, Gatsonis CA, Glasziou PP, Irwig LM et al. Towards complete and accurate reporting of studies of diagnostic accuracy: the STARD initiative. Standards for Reporting of Diagnostic Accuracy. Clin Chem 2003; 49: 1–6.
Baron-Cohen S, Wheelwright S, Skinner R, Martin J, Clubley E . The autism-spectrum quotient (AQ): evidence from Asperger syndrome/high-functioning autism, males and females, scientists and mathematicians. J Autism Dev Disord 2001; 31: 5–17.
Wheelwright S, Baron-Cohen S, Goldenfeld N, Delaney J, Fine D, Smith R et al. Predicting Autism Spectrum Quotient (AQ) from the Systemizing Quotient-Revised (SQ-R) and Empathy Quotient (EQ). Brain Res 2006; 1079: 47–56.
Wakabayashi A, Baron-Cohen S, Wheelwright S, Tojo Y . The Autism-Spectrum Quotient (AQ) in Japan: a cross-cultural comparison. J Autism Dev Disord 2006; 36: 263–270.
Hoekstra RA, Bartels M, Cath DC, Boomsma DI . Factor structure, reliability and criterion validity of the Autism-Spectrum Quotient (AQ): a study in Dutch population and patient groups. J Autism Dev Disord 2008; 38: 1555–1566.
Woodbury-Smith MR, Robinson J, Wheelwright S, Baron-Cohen S . Screening adults for Asperger Syndrome using the AQ: a preliminary study of its diagnostic validity in clinical practice. J Autism Dev Disord 2005; 35: 331–335.
Bishop DV, Maybery M, Maley A, Wong D, Hill W, Hallmayer J . Using self-report to identify the broad phenotype in parents of children with autistic spectrum disorders: a study using the Autism-Spectrum Quotient. J Child Psychol Psychiatry 2004; 45: 1431–1436.
Bertenshaw GP, Yip P, Seshaiah P, Zhao J, Chen TH, Wiggins WS et al. Multianalyte profiling of serum antigens and autoimmune and infectious disease molecules to identify biomarkers dysregulated in epithelial ovarian cancer. Cancer Epidemiol Biomarkers Prev 2008; 17: 2872–2881.
Rothman KJ . No adjustments are needed for multiple comparisons. Epidemiology 1990; 1: 43–46.
Hastie T, Tibshirani R, Friedman JH . The Elements of Statistical Learning. Springer-Verlag: New York, 2003.
Hana V, Silha JV, Justova V, Lacinova Z, Stepan JJ, Murphy LJ . The effects of GH replacement in adult GH-deficient patients: changes in body composition without concomitant changes in the adipokines and insulin resistance. Clin Endocrinol (Oxf) 2004; 60: 442–450.
Guest P, L Wang L, Harris L, Burling K, Levin Y, Ernst A et al. Increased levels of circulating insulin-related peptides in first onset, antipsychotic naïve schizophrenia patients. Mol Psychiatry 2010; 15: 118–119.
Kanda N, Tsuchida T, Tamaki K . Testosterone inhibits immunoglobulin production by human peripheral blood mononuclear cells. Clin Exp Immunol 1996; 106: 410–415.
Escobar ME, Ropelato MG, Ballerini MG, Gryngarten MG, Rudaz MC, Veldhuis JD et al. Acceleration of luteinizing hormone pulse frequency in adolescent girls with a history of central precocious puberty with versus without hyperandrogenism. Horm Res 2007; 68: 278–285.
Barontini M, Garcia-Rudaz MC, Veldhuis JD . Mechanisms of hypothalamic-pituitary-gonadal disruption in polycystic ovarian syndrome. Arch Med Res 2001; 32: 544–552.
Ragusa L, Elia M, Scifo R . Growth hormone deficit in autism. J Autism Dev Disord 1993; 23: 421–422.
Mills JL, Hediger ML, Molloy CA, Chrousos GP, Manning-Courtney P, Yu KF et al. Elevated levels of growth-related hormones in autism and autism spectrum disorder. Clin Endocrinol (Oxf) 2007; 67: 230–237.
Vanhala R, Turpeinen U, Riikonen R . Low levels of insulin-like growth factor-I in cerebrospinal fluid in children with autism. Dev Med Child Neurol 2001; 43: 614–616.
Kebapcilar L, Taner CE, Kebapcilar AG, Alacacioglu A, Sari I . Comparison of four different treatment regimens on coagulation parameters, hormonal and metabolic changes in women with polycystic ovary syndrome. Arch Gynecol Obstet; 28 March 2009 [e-pub ahead of print].
Golden SH, Ding J, Szklo M, Schmidt MI, Duncan BB, Dobs A . Glucose and insulin components of the metabolic syndrome are associated with hyperandrogenism in postmenopausal women: the atherosclerosis risk in communities study. Am J Epidemiol 2004; 160: 540–548.
Zheng Z, Li M, Lin Y, Ma Y . Effect of rosiglitazone on insulin resistance and hyperandrogenism in polycystic ovary syndrome. Zhonghua Fu Chan Ke Za Zhi 2002; 37: 271–273.
van Gent T, Heijnen CJ, Treffers PD . Autism and the immune system. J Child Psychol Psychiatry 1997; 38: 337–349.
Molloy CA, Morrow AL, Meinzen-Derr J, Schleifer K, Dienger K, Manning-Courtney P et al. Elevated cytokine levels in children with autism spectrum disorder. J Neuroimmunol 2006; 172: 198–205.
Le-Niculescu H, Kurian SM, Yehyawi N, Dike C, Patel SD, Edenberg HJ et al. Identifying blood biomarkers for mood disorders using convergent functional genomics. Mol Psychiatry 2009; 14: 156–174.
Acknowledgements
This work was funded by the Stanley Medical Research Institute, Psynova Neurotech and the Three Guineas Project Grant, Cambridge Lifespan Asperger Syndrome Service. Insulin-related assays were performed by Keith Burling at the NIHR Cambridge Biomedical Research Centre, Core Biochemistry Assay Laboratory, Addenbrookes Hospital, Cambridge, UK.
Author information
Authors and Affiliations
Corresponding authors
Ethics declarations
Competing interests
The authors declare no conflict of interest.
Additional information
Supplementary Information accompanies the paper on the Molecular Psychiatry website
Supplementary information
Rights and permissions
About this article
Cite this article
Schwarz, E., Guest, P., Rahmoune, H. et al. Sex-specific serum biomarker patterns in adults with Asperger's syndrome. Mol Psychiatry 16, 1213–1220 (2011). https://doi.org/10.1038/mp.2010.102
Received:
Revised:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1038/mp.2010.102
Keywords
This article is cited by
-
Sex, hormones and cerebrovascular function: from development to disorder
Fluids and Barriers of the CNS (2024)
-
A Proteomics Investigation of Salivary Profiles as Potential Biomarkers for Autism Spectrum Disorder (ASD)
The Protein Journal (2023)
-
Oxidative Stress in Adults with Autism Spectrum Disorder: A Case Control Study
Journal of Autism and Developmental Disorders (2022)
-
MeCP2 duplication causes hyperandrogenism by upregulating LHCGR and downregulating RORα
Cell Death & Disease (2021)
-
Gender identity, sexual orientation and adverse sexual experiences in autistic females
Molecular Autism (2020)